Related Experiment Video
Updated: Feb 13, 2026

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging
Published on: February 27, 2020
Sodium selenite attenuates lung adenocarcinoma progression by repressing SOX2-mediated stemness
Weiwei Chen1, Jiajia An1, Jiwei Guo1
1Cancer Research Institute, Binzhou Medical University Hospital, No. 661 Huanghe Street, Binzhou, 256600, Shandong, People's Republic of China.
Purpose:
Sodium selenite (SS) has been widely reported to induce apoptosis in various cancer cell types. However, the underlying molecular mechanisms governing SS-mediated repression of lung cancer stem cells remain largely undefined.
Methods:
In vitro assays of cell proliferation, clonal formation, apoptosis, migration and cancer stemness cell sphere formation were performed to examine the inhibitory effects of SS on lung adenocarcinoma (LAD) cells with or without the overexpression of SRY-related high-mobility-group box 2 (SOX2).
Results:
SS significantly inhibited cell growth and induced apoptosis in LAD cells in a dose-dependent manner with marginal effects on normal epithelial cell HBEC. SS dramatically repressed expression of SOX2 and its upstream regulator GLI1 and strongly decreased stemness sphere formation in LAD cells at 10 µM. Forced expression of SOX2 significantly buffered anti-cancer effects of SS.
Conclusions:
Our results demonstrate that SS attenuates lung adenocarcinoma progression by repressing SOX2 and its upstream regulator GLI1, which suggests that SS may be a potential therapeutic drug candidate for lung cancer patients.
Insights
Sodium selenite inhibits lung adenocarcinoma progression by targeting SOX2 and GLI1. This compound shows potential as a therapeutic agent for lung cancer, effectively reducing cancer stemness.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Sodium selenite (SS) is known to induce apoptosis in cancer cells.
- The precise mechanisms of SS in suppressing lung cancer stem cells are not fully understood.
Purpose of the Study:
- To investigate the molecular mechanisms of SS in repressing lung adenocarcinoma (LAD) stemness.
- To evaluate the effects of SS on LAD cells with varying SOX2 expression levels.
Main Methods:
- In vitro assays assessed cell proliferation, apoptosis, migration, and sphere formation.
- SOX2 and GLI1 expression levels were analyzed in LAD cells treated with SS.
- Experiments included LAD cells with and without SOX2 overexpression.
Main Results:
- SS inhibited LAD cell growth and induced apoptosis in a dose-dependent manner.
- SS significantly repressed SOX2 and GLI1 expression, reducing stemness.
- Overexpression of SOX2 partially reversed the anti-cancer effects of SS.
Conclusions:
- SS attenuates lung adenocarcinoma progression by inhibiting the SOX2/GLI1 pathway.
- SS demonstrates potential as a therapeutic drug candidate for lung cancer.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Repressed Memory
Repressible Operon: trp Operon
Lung Capacity
Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...